These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1072 related articles for article (PubMed ID: 20670755)
1. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial. Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755 [TBL] [Abstract][Full Text] [Related]
2. Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Akerblom A; James SK; Koutouzis M; Lagerqvist B; Stenestrand U; Svennblad B; Oldgren J J Am Coll Cardiol; 2010 Aug; 56(6):470-5. PubMed ID: 20670756 [TBL] [Abstract][Full Text] [Related]
3. Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). Singh HS; Dangas GD; Guagliumi G; Yu J; Witzenbichler B; Kornowski R; Grines C; Gersh B; Dudek D; Mehran R; Stone GW Am J Cardiol; 2012 Oct; 110(7):940-7. PubMed ID: 22748356 [TBL] [Abstract][Full Text] [Related]
4. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy. Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668 [TBL] [Abstract][Full Text] [Related]
5. Long-term results following switch from abciximab to eptifibatide during percutaneous coronary intervention. Koutouzis M; Lagerqvist B; Oldgren J; Akerblom A; Wahlin M; Karlsson T; Albertsson P; Matejka G; Grip L Clin Cardiol; 2010 Nov; 33(11):686-92. PubMed ID: 21089113 [TBL] [Abstract][Full Text] [Related]
6. Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction. Raveendran G; Ting HH; Best PJ; Holmes DR; Lennon RJ; Singh M; Bell MR; Long KH; Rihal CS Mayo Clin Proc; 2007 Feb; 82(2):196-202. PubMed ID: 17290727 [TBL] [Abstract][Full Text] [Related]
8. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R; JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998 [TBL] [Abstract][Full Text] [Related]
9. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698 [TBL] [Abstract][Full Text] [Related]
10. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442 [TBL] [Abstract][Full Text] [Related]
11. The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. Gurm HS; Smith DE; Collins JS; Share D; Riba A; Carter AJ; LaLonde T; Kline-Rogers E; O'Donnell M; Changezi H; Zughaib M; Safian R; Moscucci M; J Am Coll Cardiol; 2008 Feb; 51(5):529-35. PubMed ID: 18237680 [TBL] [Abstract][Full Text] [Related]
12. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G; Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313 [TBL] [Abstract][Full Text] [Related]
13. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials. Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M; JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631 [TBL] [Abstract][Full Text] [Related]
14. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial. Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177 [TBL] [Abstract][Full Text] [Related]